1. Enhancing Effector Jurkat Cell Activity and Increasing Cytotoxicity against A549 Cells Using Nivolumab as an Anti-PD-1 Agent Loaded on Gelatin Nanoparticles
   Dalia S. Ali et al, 2024, Gels CrossRef
2. Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer
   Yanling Wang et al, 2024, Heliyon CrossRef
3. B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
   Céline M. Laumont et al, 2023, Cancer Cell CrossRef